Simlandi (Adalimumab-Ryvk) is used for treating moderate to severe hidradenitis suppurativa (HS). It works by inhibiting tumor necrosis factor (TNF), which helps reduce inflammation and other symptoms associated with HS.

Common side effects
- Infections (e.g., upper respiratory and sinusitis)
- Injection site reactions
- Show Full Answer

Simlandi (Adalimumab-Ryvk) is used for treating moderate to severe hidradenitis suppurativa (HS). It works by inhibiting tumor necrosis factor (TNF), which helps reduce inflammation and other symptoms associated with HS.

Common side effects:
- Infections (e.g., upper respiratory and sinusitis)
- Injection site reactions
- Headache
- Rash

Rare but serious side effects:
- Serious infections (e.g., tuberculosis, bacterial sepsis, fungal infections)
- Increased risk of certain cancers (e.g., lymphoma)
- Anaphylaxis (severe allergic reaction)
- Reactivation of hepatitis B
- Diseases related to nerve damage
- Low levels of certain blood cells
- Heart failure
- Lupus-like syndrome

Always take Simlandi exactly as prescribed by your healthcare provider.

 This AI-generated response comes from myHSteam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Simlandi (Adalimumab-Ryvk) for Hidradenitis Suppurativa | myHSteam

Birth Control Pills for HS: What To Know | myHSteam